Xeris Pharmaceuticals | XERS - SCHULD

Aktienkurs
6.01
Täglich Wechseln
-0.08 -1.31%
Monatlich
7.32%
Jährlich
31.51%
Q2 Prognose
5.92




SCHULD Veränderung Datum
Celltrion KRW 171.09B 2.05T 2025-06
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Eli Lilly USD 42.51B 2.6B 2025-09
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Nektar Therapeutics USD 0 0 2022-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Ovoca Bio EUR 0 0 2021-06
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pharma Mar EUR 49.42M 1.98M 2025-12
Qiagen NV USD 1.81B 314.82M 2025-12
Sartorius EUR 4.28B 372.9M 2025-12
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Tilray USD 640.95M 35.17M 2022-06
Zz Pientze Pharmaceu CNY 1.07B 52.69M 2025-06